Expression_NN
of_IN
c-fos_NN
,_,
c-jun_NN
and_CC
jun_NN
B_NN
in_IN
peripheral_JJ
blood_NN
lymphocytes_NNS
from_IN
young_JJ
and_CC
elderly_JJ
adults_NNS
._.

The_DT
expression_NN
of_IN
c-fos_NN
,_,
c-jun_NN
and_CC
jun_NN
B_NN
proto-oncogenes_NNS
was_VBD
studied_VBN
in_IN
phytohemagglutinin_NN
-LRB-_-LRB-
PHA_NN
-RRB-_-RRB-
activated_VBN
peripheral_JJ
blood_NN
lymphocytes_NNS
-LRB-_-LRB-
PBL_NN
-RRB-_-RRB-
from_IN
young_JJ
and_CC
aged_JJ
humans_NNS
._.

Specific_JJ
mRNAs_NNS
for_IN
c-fos_NN
and_CC
c-jun_NN
were_VBD
detectable_JJ
within_IN
30_CD
min_NN
after_IN
cell_NN
activation_NN
and_CC
reached_VBD
maximal_JJ
levels_NNS
within_IN
2_CD
h_NN
._.

Both_CC
c-fos_NN
and_CC
jun_NN
B_NN
mRNAs_NNS
decreased_VBD
to_TO
pre-activation_NN
levels_NNS
within_IN
6_CD
h_NN
,_,
while_IN
c-jun_NN
mRNA_NN
remained_VBD
elevated_JJ
._.

In_IN
PHA-activated_JJ
PBL_NNS
,_,
no_DT
age-related_JJ
differences_NNS
were_VBD
observed_VBN
in_IN
c-fos_NN
or_CC
jun_NN
B_NN
mRNA_NN
expression_NN
._.

However_RB
,_,
c-jun_NN
mRNA_NN
levels_NNS
decreased_VBD
significantly_RB
-LRB-_-LRB-
1.73_CD
+_CC
\/_CD
-_:
0.08_CD
vs._CC
1.16_NN
+_CC
\/_NN
-_:
0.09_CD
arbitrary_JJ
units_NNS
,_,
P_NN
&lt;_JJR
0.01_CD
,_,
young_JJ
vs._CC
old_JJ
-RRB-_-RRB-
in_IN
PBL_NN
from_IN
elderly_JJ
individuals_NNS
activated_VBN
with_IN
PHA_NN
._.

Because_IN
previous_JJ
work_NN
has_VBZ
demonstrated_VBN
that_IN
T_NN
cells_NNS
from_IN
elderly_JJ
individuals_NNS
may_MD
display_VB
normal_JJ
proliferative_JJ
responses_NNS
when_WRB
activated_VBN
via_IN
the_DT
anti-CD2_JJ
pathway_NN
,_,
c-jun_NN
and_CC
jun_NN
B_NN
mRNA_NN
expression_NN
was_VBD
also_RB
studied_VBN
in_IN
anti-CD2-activated_JJ
purified_VBN
T_NN
cells_NNS
._.

No_DT
age-related_JJ
differences_NNS
were_VBD
found_VBN
in_IN
the_DT
expression_NN
of_IN
either_DT
of_IN
these_DT
two_CD
proto-oncogenes_NNS
by_IN
anti-CD2_JJ
activated_VBN
T_NN
cells_NNS
._.

These_DT
results_NNS
suggest_VBP
that_IN
the_DT
decreased_VBN
IL-2_NN
production_NN
and_CC
proliferative_JJ
response_NN
displayed_VBN
by_IN
PHA-activated_JJ
PBL_NN
from_IN
elderly_JJ
adults_NNS
may_MD
be_VB
related_JJ
to_TO
age-related_JJ
changes_NNS
in_IN
c-jun_NN
mRNA_NN
expression_NN
and_CC
in_IN
the_DT
ratio_NN
of_IN
c-fos_NN
to_TO
c-jun_NN
mRNA_NN
._.

